Upstart (UPST) Q4 2024 Earnings Call Transcript
Operator Good afternoon, and welcome to the Upstart fourth-quarter and full-year 2024 earnings call. At this time, all ...
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLIâ„¢ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...